Petrus J. de Vries - Concepedia

Author

Petrus J. de Vries

Also Known As

Charlotte Hanlon, De Vries, Petrus J., Müller, Annelieke R., P J De Vries, P J de Vries, P. J. DE VRIES, P. J. De Vries, P. J. de Vries, P.J. De Vries, P.J. de Vries

218

Publications

12.9K

Citations

H-Index

103

Concepts

All Affiliations

University of Cape Town University of Rome Tor Vergata Cincinnati Children's Hospital Medical Center University Medical Center Utrecht Sydney Children's Hospital

About

Petrus J. de Vries is an author at University of Cape Town specializing in medicine, autism, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	2.8K
2	Education	8	9	436
3	Health Sciences	3	4	141
4	Arts	1	1	81
5	Natural Sciences	1	1	14

Petrus J. de Vries

109

Publications

9.9K

Citations

H-Index

Page 1

	Year	Citations
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial John J. Bissler, J.C. Kingswood, Elżbieta Radzikowska, The Lancet Tuberous Sclerosis ComplexSporadic LymphangioleiomyomatosisPathologyPlacebo-controlled TrialScleroderma	2013	863
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial David Neal Franz, Steven Sparagana, E. Martina Bebin, The Lancet Tuberous Sclerosis ComplexNeuro-oncologyPlacebo-controlled Phase 3PathologySubependymal Giant Cell	2012	771
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study Jacqueline A. French, John A. Lawson, Hiroko Ikeda, The Lancet	2016	728
Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations Hope Northrup, Mary E. Aronow, E. Martina Bebin, Pediatric Neurology	2021	644
Tuberous Sclerosis Associated Neuropsychiatric Disorders (TAND) and the TAND Checklist Petrus J. de Vries, Vicky Whittemore, Loren Leclezio, Pediatric Neurology PsychiatryNeurological DisorderMotor DisorderNeurologyNeuroscience	2014	355
Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial D. M. Davies, Petrus J. de Vries, Simon R. Johnson, Clinical Cancer Research	2011	313
TuberOus SClerosis registry to increase disease Awareness (TOSCA) – baseline data on 2093 patients J.C. Kingswood, Guillaume Beaure d’Augères, Elena Belousova, Orphanet Journal of Rare Diseases	2017	265
Epilepsy in tuberous sclerosis complex: Findings from the <scp>TOSCA</scp> Study Rima Nabbout, Elena Belousova, Mirjana P. Benedik, Epilepsia Open	2018	222
Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 Study David Neal Franz, Steven Sparagana, E. Martina Bebin, PLoS ONE	2016	203
Global Burden of Childhood Epilepsy, Intellectual Disability, and Sensory Impairments Bolajoko O. Olusanya, Scott M. Wright, M. K. C. Nair, PEDIATRICS	2020	202

Page 1